Evidence map›Paper›PMID 29230683›Full record

ArticleJournal of gastrointestinal cancer2018

Primary Esophagogastric Neuroendocrine Carcinoma: a Retrospective Study from the Nottingham Upper Gastrointestinal Cancer Center.

Constantinos Savva, Philip Kaye, Irshad Soomro, Simon L Parsons, Eleanor James, Srinivasan Madhusudan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Prognostic value of pretreatmentFrontiers in oncology · 2023
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Constantinos SavvaDepartment of Oncology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK.
Philip KayeDepartment of Pathology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK.
Irshad SoomroDepartment of Pathology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK.
Simon L ParsonsDepartment of Surgery, Nottingham University Hospitals, Nottingham, NG5 1PB, UK.
Eleanor JamesDepartment of Oncology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK.
Srinivasan MadhusudanDepartment of Oncology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK. srinivasan.madhusudan@nottingham.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAntineoplastic AgentsCarcinoma, NeuroendocrineCombined Modality TherapyEsophagusFemaleGastrointestinal NeoplasmsHospitals, UniversityHumansMalePrognosisRetrospective StudiesStomachSurvival AnalysisTreatment OutcomeUnited KingdomAntineoplastic Agents

Identifiers

PMID29230683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.